Some proportions of populations, such as immunocompromised patients and organ
transplant recipients might have inadequate immune responses to the vaccine for …

With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …

Disclosures: C. Planchais reported a patent to PCT/EP2022/058777 licensed (SpikImm). I.
Fernández reported a patent to PCT/EP2022/058777 licensed (SpikImm). T. Bruel reported …

Reliable, easy-to-handle phenotypic screening platforms are needed for the identification of
anti-SARS-CoV-2 compounds. Here, we present caspase 3/7 activity as a readout for …

Seven coronaviruses are known to cause infection/disease in humans. Of these, human
coronavirus (HCoV)-229E and HCoV-NL63 are alphacoronaviruses (α-CoVs), whereas …

The COVID− 19 pandemic not only resulted in a global crisis, but also accelerated vaccine
development and antibody discovery. Herein we report a synthetic humanized VHH library …

Abstract Purpose of Review The purpose of our paper is to describe the all-encompassing
supportive care for patients with relapsed or refractory lymphoma undergoing cellular …

The heightened risk of infection and complexities of preventing disease in
immunocompromised individuals are at the forefront of public health strategies. The COVID …

Neutralizing monoclonal antibodies (mAbs) for pre-and post-exposure prophylaxis of Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are largely used to prevent the …

Immunocompromised patients commonly present prolonged viral shedding of the novel
coronavirus SARS-CoV-2, detected through reverse transcriptase-polymerase chain …